"No, no, you probably don't know the industry. All drugs must be supported by a five-year clinical number before they are marketed, and all side effects can be officially marketed. After marketing, it will need three years of clinical use before it can be promoted on a large scale. He leased me for five years just a concept, let me buy Nange Biotech at a low price now, and then use the concept of this drug for five years to speculate the stock price, make a lot of money and sell the shares, and get out. Then his research results are still his research results, the clinical trial time has ended, he can go directly to the Food and Drug Administration to make a report, ready for clinical use after the market, and the profit of the drug has nothing to do with Nange. He Liancheng told his plan without concealment.

Although the person who gave He Liancheng this idea is engaged in research, he is definitely not a pedant. He is not only familiar with and proficient in his own profession, but also very familiar with the operation of the capital market. I'm ashamed of myself, but after thinking about it for a while, I feel that there are still some problems with this plan.

"If you speculate on a stock in five years, will the front line be too long?" I asked.

"The larger the amount of capital, the more suitable for long-term investment, which is a bit similar to a backdoor listing. Buy a shell company that has been ST to be delisted, revitalize assets, change the direction of business, speculate on concepts and funds, wait until it is profitable to take off the hat of ST, and then take the opportunity to raise the stock price. In this way, within two or three years, if it works well, it can almost pull up the stock price by twenty or thirty times.